Skip to main content
. 2011 Nov 15;11:51. doi: 10.1186/1471-2466-11-51

Table 4.

Adverse events with an incidence > 1

Adverse event, n (%) Placebo
(n = 208)
Formoterol 4.5 μg bid (n = 206) Formoterol 9 μg bid (n = 199)
Nasopharyngitis 20 (9.6) 24 (11.7) 25 (12.6)
COPD exacerbation 17 (8.2) 10 (4.9) 8 (4.0)
Bronchitis complication 2 (1.0) 1 (0.5) 7 (3.5)
Pneumonia 0 2 (1.0) 3 (1.5)
Ill-defined disorder 2 (1.0) 2 (1.0) 1 (0.5)
Back pain 3 (1.4) 0 1 (0.5)
Dizziness 1 (0.5) 2 (1.0) 1 (0.5)
Glucose present in urine 2 (1.0) 2 (1.0) 0